Skip to main content
. 2022 Apr 20;166(2):249–264. doi: 10.1111/imm.13471

TABLE 1.

Details of total eluted peptides, HLA‐I ligandome, netMHCpan4.0 predicted binding peptides, previously reported T‐cell epitopes and peptides derived from TAA proteins from the cell surface of breast cancer, melanoma and myeloma cell lines

1. Cell lines 2. Number of eluted peptides 3. Number of peptides in HLA‐I ligandome (8‐15‐mer peptides) 4. Number of netMHCpan 4.0 binding peptides 5. Number of known immunogenic peptides identified in the study 6. Number of peptides derived from known TAA (TAApep)
MCF7 625 461 214 11 22
MDA‐MB‐231 412 406 359 11 25
MDA‐MB‐361 178 168 134 0 9
MDA‐MB‐415 827 818 700 2 52
MDA‐MB‐453 621 569 453 3 18
HCC 1806 873 756 633 6 36
HCC 1395 727 693 606 2 39
HCC 1954 842 828 720 3 44
ESTDAB‐056 804 795 717 4 40
RPMI 8226 665 650 580 1 37
Total 6574 6144 5116 43 322